Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01333553 · ClinicalTrials.gov registry record
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 69
- Enrollment target
NCT01333553: Completed study, sponsored by University of California, Irvine.
NCT01333553 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01333553 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The researcher develop non-invasive imaging modalities for assessment of port wine stain during laser therapy treatment of Port Wine Stain. The imaging modalities will be used to guide immediate retreatment of regions of persistent perfusion during the procedure.
Primary Outcome
Image-guided surgery remove Port Wine Stain
Interventions
- DEVICE Image-guided remove Port Wine Stain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-04 |
| Est. Completion | 2018-04 |
What the finished NCT01333553 record still lists
NCT01333553 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Image-guided remove Port Wine Stain is the first listed.
NCT01333553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01333553 about?
NCT01333553 is a clinical study titled "Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies". The researcher develop non-invasive imaging modalities for assessment of port wine stain during laser therapy treatment of Port Wine Stain. The imaging modalities will be used to guide immediate retreatment of regions of persistent perfusion during the procedure.
What is the current status of trial NCT01333553?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2010-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01333553?
The interventions under investigation include: Image-guided remove Port Wine Stain (DEVICE).
Who is sponsoring clinical trial NCT01333553?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia